BRISTOL-MYERS SQUIBB CO (1BMY.MI) Fundamental Analysis & Valuation
BIT:1BMY • US1101221083
Current stock price
52.8 EUR
-0.64 (-1.2%)
Last:
This 1BMY.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1BMY.MI Profitability Analysis
1.1 Basic Checks
- 1BMY had positive earnings in the past year.
- 1BMY had a positive operating cash flow in the past year.
- Of the past 5 years 1BMY 4 years were profitable.
- Each year in the past 5 years 1BMY had a positive operating cash flow.
1.2 Ratios
- 1BMY's Return On Assets of 7.83% is in line compared to the rest of the industry. 1BMY outperforms 55.56% of its industry peers.
- 1BMY's Return On Equity of 38.19% is amongst the best of the industry. 1BMY outperforms 87.04% of its industry peers.
- 1BMY has a better Return On Invested Capital (19.52%) than 77.78% of its industry peers.
- 1BMY had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 14.61%.
- The last Return On Invested Capital (19.52%) for 1BMY is above the 3 year average (14.47%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- With a Profit Margin value of 14.64%, 1BMY perfoms like the industry average, outperforming 57.41% of the companies in the same industry.
- 1BMY's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 35.82%, 1BMY belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
- 1BMY's Operating Margin has improved in the last couple of years.
- 1BMY's Gross Margin of 72.63% is in line compared to the rest of the industry. 1BMY outperforms 59.26% of its industry peers.
- In the last couple of years the Gross Margin of 1BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. 1BMY.MI Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
- Compared to 1 year ago, 1BMY has more shares outstanding
- 1BMY has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, 1BMY has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.55 indicates that 1BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.55, 1BMY perfoms like the industry average, outperforming 46.30% of the companies in the same industry.
- The Debt to FCF ratio of 1BMY is 3.51, which is a good value as it means it would take 1BMY, 3.51 years of fcf income to pay off all of its debts.
- 1BMY has a better Debt to FCF ratio (3.51) than 64.81% of its industry peers.
- A Debt/Equity ratio of 2.33 is on the high side and indicates that 1BMY has dependencies on debt financing.
- The Debt to Equity ratio of 1BMY (2.33) is worse than 81.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.55 |
ROIC/WACC2.21
WACC8.82%
2.3 Liquidity
- 1BMY has a Current Ratio of 1.26. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.26, 1BMY is in line with its industry, outperforming 40.74% of the companies in the same industry.
- A Quick Ratio of 1.14 indicates that 1BMY should not have too much problems paying its short term obligations.
- The Quick ratio of 1BMY (1.14) is better than 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. 1BMY.MI Growth Analysis
3.1 Past
- 1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
- Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
- The Revenue has decreased by -0.22% in the past year.
- 1BMY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- 1BMY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.54% yearly.
- Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -5.62% on average per year.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. 1BMY.MI Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 9.91, the valuation of 1BMY can be described as very reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 83.33% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 25.54. 1BMY is valued rather cheaply when compared to this.
- A Price/Forward Earnings ratio of 10.02 indicates a reasonable valuation of 1BMY.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 83.33% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of 1BMY to the average of the S&P500 Index (22.70), we can say 1BMY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.91 | ||
| Fwd PE | 10.02 |
4.2 Price Multiples
- 1BMY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1BMY is cheaper than 83.33% of the companies in the same industry.
- 1BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BMY is cheaper than 90.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.66 | ||
| EV/EBITDA | 7.42 |
4.3 Compensation for Growth
- The decent profitability rating of 1BMY may justify a higher PE ratio.
- A cheap valuation may be justified as 1BMY's earnings are expected to decrease with -3.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
5. 1BMY.MI Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 4.27%, 1BMY is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 1.90, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 81.48% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, 1BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
5.2 History
- On average, the dividend of 1BMY grows each year by 6.51%, which is quite nice.
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 71.52% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
- The Dividend Rate of 1BMY has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
1BMY.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1BMY (3/5/2026, 7:00:00 PM)
52.8
-0.64 (-1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners83.3%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap107.53B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target52.72 (-0.15%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
Yearly Dividend2.19
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)8.14%
PT rev (3m)16.41%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.63%
Revenue NY rev (3m)6.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.91 | ||
| Fwd PE | 10.02 | ||
| P/S | 2.58 | ||
| P/FCF | 9.66 | ||
| P/OCF | 8.77 | ||
| P/B | 6.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.42 |
EPS(TTM)5.33
EY10.09%
EPS(NY)5.27
Fwd EY9.98%
FCF(TTM)5.46
FCFY10.35%
OCF(TTM)6.02
OCFY11.41%
SpS20.5
BVpS7.86
TBVpS-9.52
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.55 |
F-Score7
WACC8.82%
ROIC/WACC2.21
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.78%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.
Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 7 / 10.
Can you provide the financial health for 1BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.
Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 71.52%.